Roche · 1 month ago
2026 Summer Intern - Frontier Research, Prescient Design
Roche is seeking exceptional graduate student interns for their Frontier Research team within Prescient Design. The role involves participating in research to advance statistical and machine learning methods for clinical trials, developing code, and preparing manuscripts for publication.
BiotechnologyHealth CareHealth DiagnosticsOncologyPharmaceuticalPrecision Medicine
Responsibilities
Participate in cutting-edge research advancing statistical and machine learning methods for the design and analysis of clinical trials
Develop well-documented code to facilitate adoption of the methods
Prepare a manuscript for submission to a scientific journal and/or conference
Qualification
Required
Must be pursuing a Ph.D. (enrolled student)
Statistics, Computer Science, Biostatistics, Applied Math, Physics, or related technical field
Excellent and proactive communication, collaboration, and interpersonal skills
Strong background and research experience in applied and/or theoretical statistics, as demonstrated by publications in statistics journals or conferences such as AISTATS, ICML, NeurIPS, etc
Strong software development skills in Python
Preferred
Prior experience working with clinicogenomic, electronic health record, or other patient biomedical data is a plus, but not required
Familiarity with survival analysis is a plus, but not required
Benefits
Paid holiday time off benefits
Company
Roche
Roche is a pharmaceutical and diagnostics company that offers medicines and diagnostic tests for various medical conditions and diseases.
H1B Sponsorship
Roche has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (12)
2024 (9)
2023 (6)
2022 (2)
2021 (2)
Funding
Current Stage
Public CompanyTotal Funding
$7.79BKey Investors
SoftBankSCALE AINovartis
2021-08-04Post Ipo Equity· $5B
2020-12-07IPO
2020-05-06Post Ipo Equity· $0.5M
Leadership Team
Recent News
Labiotech UG
2026-01-17
2026-01-16
Company data provided by crunchbase